Five CRISPR-edited PRV mutants sharpen the picture on virulence

A new Veterinary Sciences paper takes a comparative approach to pseudorabies virus genetics, examining five CRISPR/Cas9-generated PRV mutants derived from the same JM strain and individually disrupting UL21, UL24, UL50, UL56, or gG/US4. By holding the viral backbone constant, the study is designed to show how each gene shapes phenotype, including replication, plaque formation, and virulence-related behavior, rather than relying on cross-study comparisons between different strains and methods. (theherd.news)

That’s a useful contribution because PRV gene deletion is already central to both basic virology and vaccine engineering. Pseudorabies, also known as Aujeszky’s disease, was eradicated from U.S. commercial swine in 2004, but the virus remains important globally and continues to circulate in some regions, including China, where variant strains have challenged control efforts since the early 2010s. Reviews and surveillance summaries also note that PRV can infect multiple non-porcine species, and that rare human cases, largely reported in China, have heightened interest in virulence determinants and cross-species risk. (swinehealth.org)

According to the study summary, the authors generated five single-gene-disrupted JM mutants targeting genes already implicated in PRV biology and pathogenesis. Prior literature links UL21 and UL24 to virulence and host interaction, UL50 to dUTPase activity and interferon antagonism, UL56 to viral spread and pathogenicity in some models, and gG/US4 to immune modulation and use as a non-essential insertion site in recombinant constructs. The broader CRISPR literature on PRV has emphasized how much faster targeted editing has become, but also how important careful phenotypic characterization remains after each edit. (frontiersin.org)

The JM background is notable in its own right. A recent vaccine study used the same strain to construct PRV-JM-ΔEK and PRV-JM-ΔEI92K, multi-gene-deleted recombinant candidates generated with CRISPR/Cas9 technology. In that work, the more extensively deleted candidate showed favorable safety and protection findings in mice and piglets, illustrating why a cleaner understanding of single-gene effects could help researchers choose which deletions to stack in future attenuated strains. In other words, this new paper appears to supply some of the gene-by-gene groundwork that rational vaccine design needs. (mdpi.com)

I didn’t find substantial independent expert commentary tied specifically to this paper, but the surrounding literature points in the same direction. Reviews describe PRV as both an economically important swine pathogen and a useful model for studying alphaherpesvirus neurotropism, immune evasion, and attenuation strategies. Recent papers also continue to use CRISPR-based editing to build recombinant PRV strains for vaccine and vector applications, underscoring that this is an active development area rather than a one-off academic exercise. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, the immediate clinical impact is limited, but the strategic relevance is real. Better phenotypic mapping of PRV genes can improve how researchers interpret field variants, design safer live attenuated candidates, and prioritize targets for diagnostics or antiviral development. That matters most in swine systems where PRV remains endemic or where variant strains are undermining legacy control tools. It also matters from a One Health perspective, because recent reviews continue to characterize human PRV infection as rare but serious enough to justify closer attention to viral determinants of host range and neurovirulence. (onlinelibrary.wiley.com)

There’s also a practical surveillance angle. If specific disrupted genes consistently alter plaque phenotype, replication kinetics, or virulence in predictable ways, those markers can help frame how laboratories interpret emerging isolates or evaluate recombinant candidates before animal studies scale up. For veterinarians working with swine production systems, that kind of upstream research often shapes the vaccines, diagnostics, and risk messaging that reach practice a few years later. (mdpi.com)

What to watch: The next step is likely translational: whether the most informative single-gene findings from this JM comparison are folded into multi-gene deletion constructs, challenge studies in pigs, or updated variant-control strategies. Given the continued publication of JM-based recombinant PRV work and the broader push to refine attenuation without sacrificing manufacturability, this paper may end up being most important as a design map for what comes next. (mdpi.com)